Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 9538451, 4 pages
https://doi.org/10.1155/2017/9538451
Research Article

Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis

Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland

Correspondence should be addressed to Jacek C. Szepietowski; lp.corw.demu@ikswoteipezs.kecaj

Received 26 May 2017; Revised 28 July 2017; Accepted 17 August 2017; Published 28 August 2017

Academic Editor: Yona Keisari

Copyright © 2017 Joanna Salomon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. M. Voiculescu, M. Lupu, L. Papagheorghe, C. Giurcaneanu, and E. Micu, “Psoriasis and metabolic syndrome – scientific evidence and therapeutic implications,” Journal of Medicine and Life, vol. 7, pp. 468–471, 2014. View at Google Scholar
  2. I. Grozdev, N. Korman, and N. Tsankov, “Psoriasis as a systemic disease,” Clinics in Dermatology, vol. 32, pp. 343–350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Onumah and L. H. Kircik, “Psoriasis and its comorbidities,” Journal of Drugs in Dermatology, vol. 11, 5 Supplement, pp. s5–s10, 2012. View at Google Scholar
  4. A. Ogdie and P. Weiss, “The epidemiology of psoriatic arthritis,” Rheumatic Diseases Clinics of North America, vol. 41, pp. 545–568, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Yim and A. W. Armstrong, “Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms,” Rheumatology International, vol. 37, pp. 97–105, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Egeberg, “Psoriasis and comorbidities. Epidemiological studies,” Danish Medical Journal, vol. 63, article B5201, 2016. View at Google Scholar
  7. S. J. Aurangabadkar, “Comorbidities in psoriasis,” Indian Journal of Dermatology, Venereology and Leprology, vol. 79, Supplement 7, pp. S10–S17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Bussink, D. Speijer, J. M. Aerts, and R. G. Boot, “Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases,” Genetics, vol. 177, pp. 959–970, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. G. Lee, C. A. Da Silva, C. S. Dela Cruz et al., “Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling and injury,” Annual Review of Physiology, vol. 73, pp. 479–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Johansen, B. V. Jensen, A. Roslind, D. Nielsen, and P. A. Price, “Serum YKL-40, a new prognostic biomarker in cancer patients?” Cancer Epidemiology, Biomarkers & Prevention, vol. 15, pp. 194–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Imai, T. Tsuda, S. Aochi et al., “YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis,” Journal of Dermatological Science, vol. 64, pp. 75–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Imai, S. Aochi, K. Iwatsuki, H. Sano, and K. Yamanishi, “YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis,” The Journal of Dermatology, vol. 40, pp. 294–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Erfan, S. Guzel, S. Alpsoy et al., “Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?” Molecular and Cellular Biochemistry, vol. 400, pp. 207–212, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Alpsoy, A. Akyuz, G. Erfan et al., “Atherosclerosis, some serum inflammatory markers in psoriasis,” Giornale Italiano di Dermatologia e Venereologia, vol. 149, pp. 167–175, 2014. View at Google Scholar
  15. A. Ataseven, “Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40,” Giornale Italiano di Dermatologia e Venereologia, vol. 151, pp. 244–250, 2016. View at Google Scholar
  16. P. Jensen, C. Wiell, K. Milting et al., “Plasma YKL-40: a potential biomarker for psoriatic arthritis?” Journal of the European Academy of Dermatology and Venereology, vol. 27, pp. 815–819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. F. Ahmed, E. A. Attia, A. A. Saad, M. Sharara, H. Fawzy, and E. M. El Nahrery, “Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings,” Journal of the European Academy of Dermatology and Venereology, vol. 29, pp. 682–688, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Bernardi, M. Podswiadek, M. Zaninotto, L. Punzi, and M. Plebani, “YKL-40 as a marker of joint involvement in inflammatory bowel disease,” Clinical Chemistry, vol. 49, pp. 1685–1688, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Ryan and B. Kirby, “Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities,” Dermatologic Clinics, vol. 33, pp. 41–55, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. Merola, S. Wu, J. Han, H. K. Choi, and A. A. Qureshi, “Psoriasis, psoriatic arthritis and risk of gout in US men and women,” Annals of the Rheumatic Diseases, vol. 74, pp. 1495–1500, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Coimbra, C. Catarino, and A. Santos-Silva, “The triad psoriasis-obesity-adipokine profile,” Journal of the European Academy of Dermatology and Venereology, vol. 30, pp. 1876–1885, 2016. View at Publisher · View at Google Scholar · View at Scopus